Related Experiment Video
Updated: May 27, 2026

09:41
Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform
Published on: February 25, 2021
Nanoparticles in gene therapy principles, prospects, and challenges.
1Department of Pharmaceutics, School of Pharmaceutical Science, Shandong University, Shandong Province, People’s Republic of China.
Progress in Molecular Biology and Translational Science
|November 19, 2011
Summary
Nanoparticles enhance gene therapy by improving nonviral gene vector transfection efficiency. Further development of these nanomedicine delivery systems is crucial for advancing gene therapy applications.
Area of Science:
- Biomedical Engineering
- Nanomedicine
- Gene Therapy
Background:
- Genomic technologies have accelerated gene therapy prospects.
- Improving transfection efficiency of nonviral gene carriers remains a key challenge.
- Nanoparticles (NPs) offer a promising platform for advanced gene delivery systems.
Purpose of the Study:
- To review lipid- and polymer-based nonviral gene delivery vectors.
- To discuss their characteristics, advantages, and limitations.
- To present strategies for enhancing transfection efficiency in gene therapy.
Main Methods:
- Review of existing literature on nonviral gene delivery vectors.
- Analysis of lipid- and polymer-based nanoparticle components.
- Identification and description of methods to improve transfection rates.
Main Results:
- Nanoparticles serve as versatile platforms for gene delivery.
- Various lipid- and polymer-based vectors exhibit distinct properties.
- Effective strategies exist to enhance the transfection efficiency of nonviral vectors.
Conclusions:
- Nanoparticles are ideal for developing sophisticated gene delivery systems.
- Continued innovation in nonviral vector design is essential for gene therapy.
- This review aims to stimulate further research in nanomedicine for gene therapy.
Related Concept Videos
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
What is Genetic Engineering?
Overview
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
